Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice

Not Applicable

• Conditions: Cancer Metastatic
• Interventions: Radiation: Single-Fraction Palliative Radiation Therapy

• Registration Number: NCT04049188
• Lead Sponsor: Care Partners

Brief Summary

Feasibility study to report on the impact of ACCESS of single-fraction radiation therapy on cancer patients with bone metastases enrolled in hospice care.

Detailed Description

Hospice care for terminally ill patients with metastatic cancer improves quality of life, pain control, and potentially also survival when patients are enrolled early.1-3 However, hospice programs are often seen by patients and their caregivers as the last resort after exhaustion of all effective treatment options. The need to revoke active treatment (for all hospice patients with cancer outside of the VA system) discourages hospice enrollment.

This study aims to understand and analyze barriers to access specifically for short course palliative radiation therapy in cancer patients enrolled in hospice.

Study Timeline

• Study First Submitted: 2019-03-05
• Study First Submitted QC: 2019-08-06
• Study First Posted: 2019-08-08
• Status Verified: 2020-01
• Study Start: 2020-01-01
• Last Update Submitted: 2020-01-21
• Last Update Posted: 2020-01-23
• Primary Completion: 2021-01-01
• Study Completion: 2021-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

• Solid Tumor Malignancies and Multiple Myeloma with Bone Metastases and Associated Bone Pain Enrolled in Hospice

Exclusion Criteria

• Decisionally-Impaired Subjects, Pregnant Women

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Single-Fraction Palliative RT	Single-Fraction Palliative Radiation Therapy	Single-Fraction Palliative Radiation Therapy Adminstration

Primary Outcome Measures

Name	Time	Method
Change in Opioid Use for Pain Management	Through study completion, an average of 1 year	Opioid Dosage (mg/day)

Secondary Outcome Measures

Name	Time	Method
Improved Quality of Life Measures	During study completion	Questionnaires using Herth Hope Index, Timed Up and Go, and Edmonton Symptom Assessment Scale
Improved Activities of Daily Living	During study completion	Questionnaires using Hearth Hope Index, Timed Up and Go, and Edmonton Symptom Assessment Scale

Trial Locations

Locations (1)

CarePartners; 🇺🇸 Hillsboro, Oregon, United States